Who is sponsoring NCT02209909?

NCT02209909 is sponsored by Seoul National University Hospital.

What condition does NCT02209909 study?

NCT02209909 studies Coronary Artery Disease.

What drugs are being tested in NCT02209909?

Interventions: aspirin continuation, aspirin discontinuation.

What is the status of NCT02209909?

NCT02209909 is currently COMPLETED.

Last reviewed 2016-04-20 · How we verify

Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery

NCT02209909 NA COMPLETED

Platelet activation after off pump coronary artery bypass (OPCAB) surgery may affect thrombus formation. The purpose of this study is to assess the effects of preoperative continuation of aspirin on platelet activation after off pump coronary artery bypass surgery.

Details

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	COMPLETED
Enrolment	48
Start date	2014-07
Completion	2015-09

Conditions

Coronary Artery Disease

Interventions

aspirin continuation
aspirin discontinuation

Primary outcomes

change from baseline in platelet p-selectin at 48 hours after operation — after induction of anesthesia(baseline), at the time of end of operation, 24 hour after operation, 48hr after operation
Primary outcome is expression of platelet p-selectin measured by flowcytometry 48 hours after OPCAB surgery in both groups.

Countries

South Korea